WHOOP
November 24, 2024
WHOOP Unicorn News - November 24, 2024
WHOOP has launched a new feature allowing users to track the intake of substances like LSD, ketamine, and psilocybin. This innovation is part of a collaboration with the Stella Center to explore the effects of psychedelic therapies on mental health, showcasing the integration of technology in mental health treatment.
() Introduction
() Whoop Introduces Drug-Tracking Feature
WHOOP has introduced a groundbreaking feature enabling users to monitor their intake of substances such as LSD, ketamine, and psilocybin. This initiative, developed in partnership with the Stella Center, aims to deepen understanding of how psychedelic therapies impact mental health and overall well-being. By integrating advanced health tracking technology with research into alternative therapies, WHOOP is pioneering new ways to explore the potential benefits of psychedelics in treating conditions like depression, anxiety, and PTSD. This move underscores the growing role of wearable technology in supporting mental health innovation and research.
Sources
1 https://road.cc/content/tech-news/whoop-can-now-log-lsd-ketamine-and-magic-mushroom-intake-311381
Disclaimer
Investing in private securities is speculative, illiquid, and involves risk of loss. An investment with Linqto is a private placement and does not grant or transfer ownership of private company stock. No guarantee is made that a company will experience an IPO or any liquidity event.
Linqto leverages advanced artificial intelligence (AI) technologies to generate Unicorn News to summarize updates about private companies. The news summaries and audio are both AI generated, based on the source(s) listed.